Reuters -- Watson Pharmaceuticals Inc, one of the largest U.S. generic drugmakers, is more likely to take a measured approach to its international expansion than to make a “big bang” deal, the company’s chief executive said on Wednesday.
Reuters -- Watson Pharmaceuticals Inc, one of the largest U.S. generic drugmakers, is more likely to take a measured approach to its international expansion than to make a “big bang” deal, the company’s chief executive said on Wednesday.
